CD-39L4

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCD-39L4
Drug Alias NameCD-39L2CD-39L4
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionPlatelet aggregation inhibitorsEctonucleoside triphosphate diphosphohydrolase 1 agonists
TargetsEctonucleoside triphosphate diphosphohydrolase 1
Therapy Area/IndicationsThrombosisHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImperial Cancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHyseq Inc
Active IndicationsN/A
Inactive IndicationsThrombosisHeart Diseases

Other Information

ATC CodeN/A
Related LinksN/A